Navigation Links
Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine
Date:8/12/2008

Temple University School of Medicine, Fox Chase Cancer Center and Geisinger Health System today announced a research collaboration that will speed the translation of medical and health-related discoveries into significant advances in patient care.

As part of the agreement, the three institutions will form The Keystone Institute for Translational Medicine, based at Temple, to design and implement research on the genetic, behavioral, and social causes of such diseases as diabetes, hypertension, lung disease, obesity and specific cancers that disproportionately affect urban and rural Pennsylvanians.

"Together, we serve one of the most diverse patient populations in the country, putting us in a unique position to contribute significantly to translational research discoveries," said John M. Daly, M.D., dean of Temple University School of Medicine.

"We are excited to participate in The Keystone Institute for Translational Medicine," said J. Robert Beck, M.D., Fox Chase Cancer Center's senior vice president and chief academic officer. "Fox Chase Cancer Center has strong traditions in basic biomedical research, population science, and clinical trials in oncology. The Institute offers an opportunity to bridge these areas with outstanding partners to complete the cycle of bench-to-bedside-to-bench in many areas of medicine and among the diverse populations we all serve."

A special feature of the Institute is its virtual nature, which will enhance the collaboration through a social network, much like Facebook, thereby erasing the physical boundaries that separate Temple and Fox Chase researchers in Philadelphia and those at Geisinger Health System in Danville.

An overarching goal will be to engage patients in research as part of the healthcare delivery process. One such project already underway in urban Philadelphia and rural Danville is investigating the effectiveness of church-based weight loss support groups in helping people lose weight and maintain weight loss.

The three institutions are jointly pursuing a place within the National Institutes of Health's Clinical and Translational Science Award (CTSA) consortium, a network of medical research institutions across the nation.

In 2006, Temple was awarded the National Institutes of Health Clinical and Translational Science Planning Grant, which helps prepare institutions to become full-fledged CTSAs. Support from this grant has led to the master's program in Clinical Research and Translational Sciences, as well as the training and education of faculty in translational science research.

"This collaboration allows us to move beyond standard clinical and research practices to play a large role in moving knowledge from the bench to the bedside," said Glenn D. Steele, M.D., Ph.D., president and CEO of Geisinger Health System. "The synergy is expected to lead to major new therapies that can be safely and efficiently delivered to a broader healthcare market."


'/>"/>

Contact: Eryn Jelesiewicz
dobeck@temple.edu
215-707-0730
Temple University
Source:Eurekalert

Related medicine news :

1. Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee
2. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
3. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
4. HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital
5. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
6. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
7. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
8. NBTY Closes on Purchase of Leiner Health Products
9. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
10. Somanetics Announces Share Repurchase Program Increased By $15 Million
11. Assurance Investment Partners Purchases Arison Insurance Services from Anthem Blue Cross and Blue Shield
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: